PubMed

Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.

Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM.

Diabetes Care. 2007 Jun;30(6):1351-6. Epub 2007 Mar 2. Erratum in: Diabetes Care. 2007 Sep;30(9):2421. PMID: 17337492 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.

Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE.

Am J Kidney Dis. 2009 Feb;53(2):281-9. Epub 2008 Dec 19.PMID: 19100670 [PubMed - indexed for MEDLINE]Related articles

Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.

Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE.

Am J Hypertens. 2008 Dec;21(12):1330-6. Epub 2008 Nov 6.PMID: 18989258 [PubMed - indexed for MEDLINE]Related articles

Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.

Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE.

Kidney Int. 2002 Apr;61(4):1462-8.PMID: 11918753 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators.

Lancet. 2008 Aug 16;372(9638):547-53.PMID: 18707986 [PubMed - indexed for MEDLINE]Related articles

The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).

Williams B, Gosse P, Lowe L, Harper R; PRISMA I Study Group.

J Hypertens. 2006 Jan;24(1):193-200.PMID: 16331118 [PubMed - indexed for MEDLINE]Related articles

Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.

Sharma A, Baliga V; TRIUMPH Study Group.

J Indian Med Assoc. 2008 Mar;106(3):191-4, 196.PMID: 18712142 [PubMed - indexed for MEDLINE]Related articles

Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.

Sengul AM, Altuntas Y, Kürklü A, Aydin L.

Diabetes Res Clin Pract. 2006 Feb;71(2):210-9. Epub 2005 Aug 19.PMID: 16112244 [PubMed - indexed for MEDLINE]Related articles

The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials.

Gosse P, Neutel JM, Schumacher H, Lacourcière Y, Williams B, Davidai G.

Blood Press Monit. 2007 Jun;12(3):141-7.PMID: 17496463 [PubMed - indexed for MEDLINE]Related articles

Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?

Schmieder RE.

J Hypertens Suppl. 2006 Apr;24(2):S31-5. Review.PMID: 16601559 [PubMed - indexed for MEDLINE]Related articles

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. Epub 2008 Mar 31.PMID: 18378520 [PubMed - indexed for MEDLINE]Related articlesFree article

Rationale and design of diabetics exposed to telmisartan and enalapril (DETAIL) study.

Rippin J, Bain SC, Barnett AH; DETAIL study.

J Diabetes Complications. 2002 May-Jun;16(3):195-200.PMID: 12015188 [PubMed - indexed for MEDLINE]Related articles

Ventricular and vascular remodelling effects of the angiotensin II receptor blocker telmisartan and/or the angiotensin-converting enzyme inhibitor ramipril in hypertensive patients.

Petrovic I, Petrovic D, Vukovic N, Zivanovic B, Dragicevic J, Vasiljevic Z, Babic R.

J Int Med Res. 2005;33 Suppl 1:39A-49A.PMID: 16222899 [PubMed - indexed for MEDLINE]Related articles

Assessment of endothelial function of the renal vasculature in human subjects.

Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE.

Am J Hypertens. 2002 Jan;15(1 Pt 1):3-9.PMID: 11824856 [PubMed - indexed for MEDLINE]Related articles

Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.

Derosa G, Ragonesi PD, Mugellini A, Ciccarelli L, Fogari R.

Hypertens Res. 2004 Jul;27(7):457-64.PMID: 15302981 [PubMed - indexed for MEDLINE]Related articlesFree article

Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: a comparative study.

Symeonides P, Koulouris S, Vratsista E, Triantafyllou K, Ioannidis G, Thalassinos N, Katritsis D.

Eur J Echocardiogr. 2007 Dec;8(6):480-6. Epub 2006 Nov 17.PMID: 17113349 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.

Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F.

Diabetes Care. 1998 Apr;21(4):631-6.PMID: 9571355 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Böhm M, Williams B, Pogue J, Koon T, Yusuf S; ONTARGET investigators.

J Hypertens. 2009 Jul;27(7):1360-9.PMID: 19506526 [PubMed - indexed for MEDLINE]Related articles

Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.

Tietze IN, Sørensen SS, Ivarsen PR, Nielsen CB, Pedersen EB.

J Hypertens. 1997 May;15(5):551-60.PMID: 9170009 [PubMed - indexed for MEDLINE]Related articles

Telmisartan improves endothelial function in patients with essential hypertension.

Benndorf RA, Appel D, Maas R, Schwedhelm E, Wenzel UO, Böger RH.

J Cardiovasc Pharmacol. 2007 Oct;50(4):367-71.PMID: 18049303 [PubMed - indexed for MEDLINE]Related articles